Sanford Burnham Prebys Medical Discovery Institute
📖 Wiki Page
institution856 wordssynced 2026-04-02
Introduction
Sanford Burnham Prebys Medical Discovery Institute is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-institution [@proceedings2024] | Sanford Burnham Prebys | | [@neuron] |---|---| [@cell] | Location | La Jolla, CA, USA | [@nature] | Type | Independent Medical Research Institute | | Founded | 1976 | | Website | [sbpdiscovery.org](https://www.sbpdiscovery.org) | ::
Sanford Burnham Prebys Medical Discovery Institute is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-institution [@proceedings2024] | Sanford Burnham Prebys | | [@neuron] |---|---| [@cell] | Location | La Jolla, CA, USA | [@nature] | Type | Independent Medical Research Institute | | Founded | 1976 | | Website | [sbpdiscovery.org](https://www.sbpdiscovery.org) | ::
Overview
Mermaid diagram (expand to render)
Sanford Burnham Prebys Medical Discovery Institute is a premier independent biomedical research institute located in La Jolla, California, specializing in cancer research, neuroscience, diabetes, and infectious diseases. Founded in 1976, the institute has established itself as a leader in basic and translational biomedical research, with particular strength in understanding the molecular mechanisms underlying neurodegenerative diseases. The institute's neuroscience program has become a major focus area, with significant resources dedicated to understanding and developing treatments for Alzheimer's disease, Parkinson's disease, and related disorders.
Neurodegeneration Research Programs
Neuroscience and Aging Program
The neuroscience program at Sanford Burnham Prebys encompasses a comprehensive approach to neurodegenerative disease research:
Alzheimer's disease drug discovery focusing on novel therapeutic targets
Parkinson's disease research including [alpha-synuclein](/proteins/alpha-synuclein) biology and LRRK2 mechanisms
Neuroinflammation studies examining microglial activation and neuroimmune crosstalk
Protein aggregation mechanisms underlying various neurodegenerative conditions
Aging research addressing the fundamental biology of neuronal senescence
Center for Alzheimer's Disease Research
The Center for Alzheimer's Disease Research represents a major initiative at Sanford Burnham Prebys:
[Tau](/proteins/tau) biology and therapeutics development targeting [tau](/proteins/tau) pathology
Amyloid precursor protein (APP) processing studies
Neuroprotective strategies for maintaining neuronal health
Biomarker development for early detection and disease monitoring
Translation of basic science discoveries into clinical applications
Parkinson's Disease Research
Parkinson's disease research programs include:
Alpha-synuclein biology and aggregation mechanisms
LRRK2 kinase research and inhibitor development
Mitochondrial dysfunction in dopaminergic [neurons](/entities/neurons)
Neurotrophic factor research for neuronal protection
Drug discovery targeting disease-modifying therapies
Key Research Areas
Alzheimer's Disease
The Alzheimer's disease research program covers:
[APP](/entities/app-protein) processing pathways and [gamma-secretase](/proteins/gamma-secretase) modulation
[Tau](/proteins/tau) pathology from oligomers to neurofibrillary tangles
Drug discovery using high-throughput screening approaches
Stem cell models for disease modeling
Neuroinflammation as a therapeutic target
Parkinson's Disease
Parkinson's disease research includes:
Alpha-synuclein aggregation and strain diversity
LRRK2 biology and pathogenic mutations
Mitochondrial quality control mechanisms
[Autophagy](/entities/autophagy) and lysosomal dysfunction
Neuroinflammation in dopaminergic degeneration
Neuroinflammation
Research on neuroinflammation focuses on:
Microglial activation states and their role in neurodegeneration
Neuroimmune crosstalk between neurons and glia
[Complement system](/entities/complement-system) involvement in synaptic loss
[TREM2](/proteins/trem2-protein) and other microglial receptor biology
Therapeutic modulation of neuroinflammation
Protein Homeostasis
The protein homeostasis program examines:
Protein folding mechanisms and molecular chaperones
Quality control pathways including [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system)
Autophagy-lysosomal degradation pathways
Protein aggregation nucleation and propagation
Interventions to enhance protein clearance
Notable Discoveries and Contributions
Sanford Burnham Prebys has made significant contributions to neurodegenerative disease research:
Pioneering work in [gamma-secretase](/entities/gamma-secretase) modulation for Alzheimer's disease therapy
Discovery of novel tau oligomerization inhibitors
Development of stem cell models for neurodegeneration research
Identification of novel therapeutic targets in neuroinflammation
Advanced understanding of [alpha-synuclein](/proteins/alpha-synuclein) biology
Drug Discovery Programs
The institute maintains active drug discovery programs:
High-throughput screening for novel therapeutic compounds
Medicinal chemistry optimization of hit compounds
Preclinical validation in cellular and animal models
Partnership with pharmaceutical companies for clinical development
Focus on disease-modifying rather than symptomatic treatments
Core Facilities
Sanford Burnham Prebys provides state-of-the-art research facilities:
Rodent behavior core for cognitive and motor testing
In vivo imaging center including MRI and PET
Stem cell biology core for disease modeling
High-throughput screening facility for drug discovery
Proteomics and genomics cores for molecular analysis
Collaborative Networks
The institute maintains extensive collaborative networks:
NIH-funded research grants across multiple institutes
Alzheimer's Drug Discovery Foundation partnerships
Michael J. Fox Foundation for Parkinson's Research collaborations
Industry partnerships for drug development
International research consortia
Future Directions
Sanford Burnham Prebys continues to advance neurodegenerative disease research through:
Expansion of precision medicine approaches
Development of biomarkers for patient stratification
Enhancement of translational research capabilities
Recruitment of additional faculty in key areas
Investment in novel therapeutic modalities
Background
The study of Sanford Burnham Prebys Medical Discovery Institute has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.